Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-03-01 @ 4:46 PM
Study NCT ID:
NCT03724968
Status:
TERMINATED
Last Update Posted:
2021-04-20
First Post:
2018-10-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
Sponsor:
Elizabeth Davis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-26
First Submit QC Date:
None
Study First Post Date:
2018-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-02-12
Results First Submit QC Date:
None
Results First Post Date:
2021-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-26
Last Update Post Date:
2021-04-20
Last Update Post Date Type:
ACTUAL